IMS Health Incorporated - Strategic SWOT Analysis Review

  • February 2014
  • -
  • Global Data
  • -
  • 29 pages

IMS Health Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

IMS Health Incorporated (IMS Health) is a provider of information, services and technology to the healthcare industry around the world. The company helps its clients comprehend the dynamics and performance of healthcare systems through its global technology infrastructure and a combination of sophisticated analytics, software platforms, and onshore and offshore commercial services. IMS Health serves decision makers in the healthcare industry, including pharmaceutical manufacturers and distributors, government agencies, policymakers, providers, payers, researchers and the financial community.

IMS Health Incorporated Key Recent Developments

Sep 16, 2013: IMS Health and BroadReach Healthcare Announce Strategic Alliance in Africa
Jul 25, 2013: IMS Health to Issue Second-Quarter 2013 Financial Results on July 30, Conference Call for Note Holders Scheduled for July 31

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

IMS Health Incorporated - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables
Section 1 - About the Company 4
IMS Health Incorporated - Key Facts 4
IMS Health Incorporated - Key Employees 5
IMS Health Incorporated - Key Employee Biographies 7
IMS Health Incorporated - Major Products and Services 8
IMS Health Incorporated - History 9
IMS Health Incorporated - Company Statement 13
IMS Health Incorporated - Locations And Subsidiaries 14
Head Office 14
Other Locations and Subsidiaries 14
Section 2 - Company Analysis 22
IMS Health Incorporated - Business Description 22
IMS Health Incorporated - SWOT Analysis 23
SWOT Analysis - Overview 23
IMS Health Incorporated - Strengths 23
Strength - Wide Portfolio of Services 23
Strength - Strong Operational Base 23
Strength - Wide Geographical Presence 23
IMS Health Incorporated - Weaknesses 23
Weakness - Involvement in Litigations 23
Weakness - Lack of Business Transparency 23
IMS Health Incorporated - Opportunities 24
Opportunity - New Product Launches 24
Opportunity - Strategic Growth Initiatives 24
Opportunity - Inorganic Growth 24
IMS Health Incorporated - Threats 25
Threat - Technological Advancements 25
Threat - Intellectual Property at Risk 25
Threat - Privacy Laws 25
IMS Health Incorporated - Key Competitors 26
IMS Health Incorporated, Recent Deals Summary 27
Section 3 - Company's Recent Developments 28
IMS Health Incorporated, Recent Developments 28
Sep 16, 2013: IMS Health and BroadReach Healthcare Announce Strategic Alliance in Africa 28
Jul 25, 2013: IMS Health to Issue Second-Quarter 2013 Financial Results on July 30, Conference Call for Note Holders Scheduled for July 31 28
Section 4 - Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables

IMS Health Incorporated, Key Facts 4
IMS Health Incorporated, Key Employees 5
IMS Health Incorporated, Key Employee Biographies 7
IMS Health Incorporated, Major Products and Services 8
IMS Health Incorporated, History 9
IMS Health Incorporated, Other Locations 14
IMS Health Incorporated, Subsidiaries 21
IMS Health Incorporated, Key Competitors 26
IMS Health Incorporated, Recent Deals Summary 27

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

RTI Surgical, Inc. (RTIX) - Product Pipeline Analysis, 2014 Update

RTI Surgical, Inc. (RTIX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary RTI Surgical, Inc. (RTI), formerly RTI Biologics, Inc., is a surgical implant company. The company develops and markets biologic, metal and synthetic implants. Its products include spine implants, ...

Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update

Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Transfusion & Transplantation Technologies (3Ti) is a diagnostic company. The company develops automated technology for the diagnostic testing of blood associated with blood transfusions. Its flagship ...

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Orion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.